1. Home
  2. MDGL vs BMI Comparison

MDGL vs BMI Comparison

Compare MDGL & BMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • BMI
  • Stock Information
  • Founded
  • MDGL 2011
  • BMI 1905
  • Country
  • MDGL United States
  • BMI United States
  • Employees
  • MDGL N/A
  • BMI N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • BMI Industrial Machinery/Components
  • Sector
  • MDGL Health Care
  • BMI Industrials
  • Exchange
  • MDGL Nasdaq
  • BMI Nasdaq
  • Market Cap
  • MDGL 6.8B
  • BMI 6.4B
  • IPO Year
  • MDGL N/A
  • BMI N/A
  • Fundamental
  • Price
  • MDGL $290.96
  • BMI $244.90
  • Analyst Decision
  • MDGL Strong Buy
  • BMI Buy
  • Analyst Count
  • MDGL 10
  • BMI 6
  • Target Price
  • MDGL $420.63
  • BMI $227.67
  • AVG Volume (30 Days)
  • MDGL 361.7K
  • BMI 272.5K
  • Earning Date
  • MDGL 05-01-2025
  • BMI 04-17-2025
  • Dividend Yield
  • MDGL N/A
  • BMI 0.56%
  • EPS Growth
  • MDGL N/A
  • BMI 30.84
  • EPS
  • MDGL N/A
  • BMI 4.54
  • Revenue
  • MDGL $317,383,000.00
  • BMI $852,489,000.00
  • Revenue This Year
  • MDGL $264.55
  • BMI $13.05
  • Revenue Next Year
  • MDGL $67.21
  • BMI $8.20
  • P/E Ratio
  • MDGL N/A
  • BMI $53.78
  • Revenue Growth
  • MDGL N/A
  • BMI 15.08
  • 52 Week Low
  • MDGL $200.08
  • BMI $162.17
  • 52 Week High
  • MDGL $377.46
  • BMI $239.11
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.85
  • BMI 72.87
  • Support Level
  • MDGL $280.00
  • BMI $239.79
  • Resistance Level
  • MDGL $307.54
  • BMI $249.65
  • Average True Range (ATR)
  • MDGL 15.97
  • BMI 5.90
  • MACD
  • MDGL -2.00
  • BMI 1.72
  • Stochastic Oscillator
  • MDGL 15.88
  • BMI 86.77

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About BMI Badger Meter Inc.

Badger Meter Inc is an innovator, manufacturer, and marketer of products incorporating flow measurement, quality, control, and other system solutions serving markets. The company's products measure water, oil, chemicals, and other fluids, and provide and communicate timely measurement data. Its product lines include two categories: sales of water meters, radios, software, and related technologies, and water quality monitoring solutions to water utilities (utility water) and sales of meters and other sensing instruments, valves, software, and other solutions for industrial applications in water, wastewater, and other industries (flow instrumentation). It derives a majority of its revenues from the United States.

Share on Social Networks: